These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19115206)

  • 1. Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression.
    Mizuuchi E; Semba S; Kodama Y; Yokozaki H
    Int J Cancer; 2009 Apr; 124(8):1802-10. PubMed ID: 19115206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
    Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
    Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of phosphatase of regenerating liver-3 for the nucleolar localization of nucleolin during the progression of colorectal carcinoma.
    Semba S; Mizuuchi E; Yokozaki H
    Cancer Sci; 2010 Oct; 101(10):2254-61. PubMed ID: 20860603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of p53 by phosphatase of regenerating liver 3 is mediated by MDM2 and PIRH2.
    Min SH; Kim DM; Heo YS; Kim HM; Kim IC; Yoo OJ
    Life Sci; 2010 Jan; 86(1-2):66-72. PubMed ID: 19945467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
    Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
    J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ; Keller PJ; Cox AD
    Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
    Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
    Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo.
    Matsukawa Y; Semba S; Kato H; Koma Y; Yanagihara K; Yokozaki H
    Pathobiology; 2010; 77(3):155-62. PubMed ID: 20516731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRL-3: a metastasis-associated phosphatase in search of a function.
    Bessette DC; Wong PC; Pallen CJ
    Cells Tissues Organs; 2007; 185(1-3):232-6. PubMed ID: 17587829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of phosphatase of regenerating liver-3 mRNA and its clinical implications in human colorectal carcinoma].
    Zhao GP; Zhou ZG; Lei WZ; Yu YY; Zheng XL; Gao HK
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):237-40. PubMed ID: 16167237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells.
    Wu X; Zeng H; Zhang X; Zhao Y; Sha H; Ge X; Zhang M; Gao X; Xu Q
    Am J Pathol; 2004 Jun; 164(6):2039-54. PubMed ID: 15161639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
    Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.
    Wang H; Quah SY; Dong JM; Manser E; Tang JP; Zeng Q
    Cancer Res; 2007 Apr; 67(7):2922-6. PubMed ID: 17409395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical assessment of PRL-3 (PTP4A3) expression in tumor buds, invasion front, central region of tumor and metastases of colorectal cancer.
    Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Ustymowicz M
    Adv Med Sci; 2011; 56(1):39-43. PubMed ID: 21555304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositides.
    McParland V; Varsano G; Li X; Thornton J; Baby J; Aravind A; Meyer C; Pavic K; Rios P; Köhn M
    Biochemistry; 2011 Sep; 50(35):7579-90. PubMed ID: 21806020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRL-3 expression in metastatic cancers.
    Bardelli A; Saha S; Sager JA; Romans KE; Xin B; Markowitz SD; Lengauer C; Velculescu VE; Kinzler KW; Vogelstein B
    Clin Cancer Res; 2003 Nov; 9(15):5607-15. PubMed ID: 14654542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRL-3 improves colorectal cancer cell proliferation and invasion through IL-8 mediated glycolysis metabolism.
    Xu H; Zeng Y; Liu L; Gao Q; Jin S; Lan Q; Lai W; Luo X; Wu H; Huang Y; Chu Z
    Int J Oncol; 2017 Oct; 51(4):1271-1279. PubMed ID: 28791350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
    Zhou J; Wang S; Lu J; Li J; Ding Y
    Int J Cancer; 2009 Apr; 124(8):1879-86. PubMed ID: 19101992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-associated silencing of miR-495 inhibit the migration and invasion of human gastric cancer cells by directly targeting PRL-3.
    Li Z; Zhang G; Li D; Jie Z; Chen H; Xiong J; Liu Y; Cao Y; Jiang M; Le Z; Tan S
    Biochem Biophys Res Commun; 2015 Jan; 456(1):344-50. PubMed ID: 25475733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Snail as a key regulator of PRL-3 gene in colorectal cancer.
    Zheng P; Meng HM; Gao WZ; Chen L; Liu XH; Xiao ZQ; Liu YX; Sui HM; Zhou J; Liu YH; Li JM
    Cancer Biol Ther; 2011 Oct; 12(8):742-9. PubMed ID: 21811102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.